Digostics, a UK-based diabetes home-testing provider, who graduated from our NHS Market Access Accelerator programme in 2022 have partnered with Medway NHS Foundation Trust to transform local gestational diabetes screening, by offering world-first home oral glucose tolerance testing (OGTT) technology to all at-risk women.
Medway NHS Foundation Trust, one of the largest and most innovative NHS trusts in the South-East of England, has taken a bold step forward in its virtual care journey by transitioning to a new digital platform – part of its…
Chancellor Rachel Reeves announced that the government is investing up to £10bn to bring the NHS “into the digital age” as part of the latest spending review.
Read more here.